Treatment adult idiopathic nephrotic syndrome cyclosporin minimal-change disease focal-segmental glomerulosclerosis Collaborative Group French Society Nephrology open studies efficacy tolerance cyclosporin CyA Sandimmun mg/kg/day Sixty-four patients CyA monotherapy efficacy months patients CyA prednisone mg/kg/day efficacy months patients adverse events reasons patients protocol violation patients valid evaluation efficacy minimal-change disease MCD focal-segmental glomerulosclerosis FSGS steroid-dependent SD steroid-resistant SR remission failure rate histology MCD FSGS steroid response SD SR rate remission SD MCD SR FSGS Tolerance serum creatinine cases repeat renal biopsy months Serum creatinine stable MCD creatinines cases SR FSGS pretreatment interstitial lesions due increase interstitial lesions progression glomerular lesions FSGS 